ISU Abxis Co., Ltd.
Developing antibody-based immunotherapies for oncology and rare diseases.
086890 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 대왕판교로712번길 22, 씨동 5층 (삼평동, 글로벌알앤디센터), 성남시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ISU Abxis Co., Ltd. is a biopharmaceutical company that pioneers the discovery and development of engineered antibody-based immunotherapies. The company leverages its advanced antibody technology platform to address significant unmet medical needs in oncology and rare diseases. Its pipeline includes therapeutic candidates such as ISU104 for solid tumors and Fabagal, a treatment for Fabry disease. Founded in 2001, the company is dedicated to developing novel bio-therapeutics to enhance the quality of life for patients with difficult-to-treat conditions.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for ISU Abxis Co., Ltd. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
Automate Your Workflow. Get a real-time feed of all ISU Abxis Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for ISU Abxis Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
